NCT00228410View on ClinicalTrials.gov

Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections

PHASE3CompletedINTERVENTIONAL

Enrollment

503

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

Skin Diseases, Infectious

Interventions

DRUG

Tigecycline

DRUG

vancomycin with aztreonam

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00228410 - Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections | Biotech Hunter | Biotech Hunter